DUBLIN--(BUSINESS WIRE)--The "Imaging Agents - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Imaging Agents in US$ by the following Product Segments:
- Contrast Media (X-Ray/CT, MRI, & Ultrasound)
- Diagnostic Radiopharmaceuticals.
The report profiles 52 companies including many key and niche players such as:
- 3B Pharmaceuticals
- Advanced Accelerator Applications
- Aytu BioScience, Inc.
- Bayer Healthcare Pharmaceuticals
- Blue Earth Diagnostics
- Bracco Diagnostics, Inc.
- Bracco-Eisai Co., Ltd
- Daiichi Sankyo Company Limited
- Eli Lilly and Company
- GE Healthcare
- Ground Fluor Pharmaceuticals
- Guerbet Group
- IBA Molecular
- Lantheus Medical Imaging, Inc.
- Piramal Imaging SA
Key Topics Covered:
1. Industry Overview
2. Segmental Overview And Competitive Landscape
3. Market Trends & Issues
4. Global Medical Imaging Market
5. Product Overview
6. Technology Dynamics
7. Product Innovations/Introductions/ Approvals
8. Recent Industry Activity
9. Focus On Select Players
10. Global Market Perspective
Total Companies Profiled: 52 (including Divisions/Subsidiaries 60)
- The United States (33)
- Canada (2)
- Japan (1)
- France (3)
- Germany (5)
- The United Kingdom (2)
- Italy (2)
- Rest of Europe (6)
- Asia-Pacific (Excluding Japan) (5)
- Africa (1)
For more information about this report visit https://www.researchandmarkets.com/research/h4vsfq/global_imaging?w=4